Hostname: page-component-74656f9884-rdgjk Total loading time: 0 Render date: 2026-11-07T09:58:01.743Z Has data issue: false hasContentIssue false

Feeding, growth, nutrition, and optimal interstage surveillance for infants with hypoplastic left heart syndrome

Published online by Cambridge University Press:  13 December 2011

David A. Hehir*
Affiliation:
Division of Pediatric Cardiology, Children's Hospital of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America Division of Pediatric Critical Care Medicine, Children's Hospital of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America
David S. Cooper
Affiliation:
The Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America
Elizabeth M. Walters
Affiliation:
The Heart Center, All Children's Hospital, Miami, Florida, United States of America
Nancy S. Ghanayem
Affiliation:
Division of Pediatric Critical Care Medicine, Children's Hospital of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America
*
Correspondence to: Dr D. A. Hehir, MD, 9000 West Wisconsin Avenue, Milwaukee, Wisconsin 53201, United States of America. Tel: 414-266-5711; Fax: 414-266-3563; E-mail: dhehir@mcw.edu
Rights & Permissions [Opens in a new window]

Abstract

Improvement in operative survival of patients with hypoplastic left heart syndrome has led to increasing emphasis on prevention of interstage mortality. Many centres have improved interstage results through programmes of home monitoring following discharge after the Norwood (Stage 1) operation. Experience with heightened interstage surveillance has identified failure to thrive during infancy as a modifiable risk factor for this population, one that has been linked to concerning outcomes at subsequent palliative surgeries. Ensuring normal growth as an infant has thus become a priority of management of patients with functionally univentricular hearts. Herein, we review the existing evidence for best practices in interstage surveillance and optimal nutrition in infants with functionally univentricular hearts. In addition, we highlight data presented at HeartWeek 2011, from Cardiology 2011, the 15th Annual Update on Pediatric and Congenital Cardiovascular Disease, and the 11th Annual International Symposium on Congenital Heart Disease.

Figure 0

Table 1 Studies reporting interstage mortality.

Figure 1

Table 2 Studies reporting growth of infants with hypoplastic left heart syndrome.